Categorizing immune responders with fusion metrics and simulation for association to survival & progression free survival with immune response in HLA-A2+ patients with GBM from a phase 2 trial of dendritic cell (DC) immunotherapy (ICT-107)., Radleigh Santos, Clemencia Pinilla, Steve J. Swanson, Anthony Gringeri, John Yu
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures

Using Fusion of Response Metrics and Monte Carlo Simulation to Determine Immune Response in Cancer Immunotherapy Patients, Radleigh Santos, Alcinette Bunying, Nazila Sabri, John Yu, Steve J. Swanson, Valeria A. Judkowski, Pedro Romero, Sylvia Janetzki, Clemencia Pinilla
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures

Association of Survival and Progression-Free Survival with Immune Response in HLA-A2+ Newly- Diagnosed GBM Patients in Randomized Double-Blind Placebo-Controlled Phase 2 Trial of Dentritic Cell (DC) Immunotherapy with ICT-107, Patrick Wen, David Reardon, Surasak Phuphanich, Robert Aiken, Joseph Landolfi, William Curry, Jay-Jiguang Zhu, Michael Glantz, David Peereboom, James Markert, Renato Larocca, Donald O'Rourke, Karen Fink, Lyndon Kim, Michael Gruber, Glenn Lesser, Ed Pan, Radleigh Santos, Clemencia Pinilla, John Yu
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures

Statistically significant association of glioblastoma immunotherapy phase II clinical study (ICT-107) treatment and survival to immune response using a novel comprehensive ELISPOT analysis., Radleigh Santos, Anthony Gringeri, John Yu, Sylvia Janetzki, Valeria A. Judkowski, Clemencia Pinilla
Mathematics Faculty Proceedings, Presentations, Speeches, Lectures

Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis, Radleigh Santos, Alcinette Bunying, Nazila Sabri, John Yu, Anthony Gringeri, James Bender, Sylvia Janetzki, Clemencia Pinilla, Valeria A. Judkowski
Mathematics Faculty Articles